Canine distemper virus (CDV) is a highly contagious viral pathogen of worldwide distribution that can cause lethal disease in domestic dogs and other members of the family Canidae. Genetic diversity is found among reference strains and isolates of CDV, mainly in the haemagglutinin (H) protein, and this may be associated with the increasing incidence of distemper in dogs. CDV was isolated in Vero cells expressing canine signalling lymphocyte activation molecule (Vero.DogSLAM) from peripheral blood mononuclear cells and spleen of clinically diseased, previously vaccinated South African dogs. Direct fluorescence antibody test and electronmicroscopy were used to confirm the isolation procedure. Subsequently, RT-PCR was performed on the cell culture isolates, the amplified products were purified and the complete H gene was sequenced and phylogenetically analysed. The H gene of vaccines in use in South Africa was also sequenced and comparative analyses performed. However, the sequences obtained from the sick dogs showed 100% nucleotide identity and was different to that found in virus strains used in vaccines and in isolates reported from other parts of the world in GenBank. The results suggest that a novel CDV lineage may be present in South Africa and we conclude that a recent reversion of vaccine virus to virulence was not the cause of the clinical signs seen in dogs with a previous history of vaccination.
INTRODUCTION
Canine distemper is an acute or subacute, highly contagious disease with signs of generalized infection, respiratory disease, foot pad hyperkeratosis, central nervous system disturbance or a combination of these (Appel and Summers, 1999) . Distemper affects wild and domestic Canidae as well as many other species of carnivores (Appel, 1987) . The aetiological agent is canine distemper virus (CDV) which belongs to the genus Morbillivirus within the family Paramyxoviridae. CDV contains two glycoproteins; haemagglutinin (the attachment protein) and a fusion protein, which are the major target antigens for the host immune system (Murphy et al., 1999) . The introduction of the live modified CDV vaccines in the 1950s and their extensive use has greatly helped to keep the disease under control (Chappuis, 1995) . Notwithstanding, the incidence of CDV-related disease in canine population throughout the world seems to have increased in the last decades and several episodes of CDV disease in vaccinated animals have been reported (BlixenkronMoller et al., 1993; Decaro et al., 2004; Gemma et al., 1996; Kai et al., 1993; Scagliarini et al., 2003) Sequence analysis of CDV strains identified in different geographical settings and from various animal species has revealed that the H gene/glycoprotein of CDV undergoes a genetic/antigenic drift, according to geographic patterns related to the location of the circulating strains (Bolt et al., 1997; Haas et al., 1999; Iwatsuki et al., 2000; Martella et al., 2006) . Herewith, we describe the genetic characterization of canine distemper viruses detected from naturally infected but previously vaccinated dogs in South Africa.
MATERIALS AND METHODS

Viruses and clinical specimens
Five CDV strains were sequenced in this study. The CDV-positive cases were identified by screening animals affected with neurological signs, enteritis, or respiratory distress and with a prior history of CDV vaccination. These samples were submitted by animal hospitals and shelters in various parts of Pretoria during 2007. Specimens obtained from living dogs were limited to blood in heparin-containing tubes and spleen from dogs that were euthanized or died with signs of canine distemper. Peripheral blood mononuclear cells (PBMCs) were extracted from the blood samples as previously described (Woma and van Vuuren, 2009) , while necropsy tissues were processed on receipt as described by Seki et al., (2003) . Each processed specimen was individually inoculated at a volume of 0.5 ml into a 25 cm 2 plastic tissue culture flask containing a subconfluent monolayer of Vero.DogSLAM cells (Woma and van Vuuren, 2009 ).
Reverse transcription, PCR amplification and Sequencing
Reverse transcription and PCR amplification of the H gene of CDV was achieved as previously described (Woma et al., 2010) . Total RNA was obtained from 200 µl of supernatants of infected cells and 5 commercial CDV vaccines (200 µl) , used in South Africa with the aid of the RNeasy mini kit (Qiagen®) according to the manufacturer's instructions.
The vaccines are not produced in South Africa and different strains are employed for their production. They were initially diluted as prescribed by the manufacturers for injection in dogs.
The amplified PCR products were purified using a QIA quick® PCR purification kit (Qiagen®, Southern Cross Biotechnology) according to the manufacturer's instructions. Purified products were directly sequenced with a Big Dye® Terminator v.3.1 cycle sequencing kit (AppliedBiosystems) according to the manufacturer's instructions. The internal H gene sequence primers were P2F, P3R, P5R, CDV-HS1, CDV-HforD and CDV-Hr2 (Table II) (Lan et al., 2006; Pardo et al., 2005) . Precipitation of extension products was by the ethanol precipitation protocol of AppliedBiosystems®. Sequence trace files were electrophoresed using the SpectruMedix Genetics analysis system SCE 2410 of Inqaba Biotech (South Africa) and the ABI 3130XL Genetic analyser of the Genetics Laboratory, Equine Research Centre, Faculty of Veterinary Science, University of Pretoria.
Phylogenetic analyses
Sequence data of the full length H gene were assembled and edited to a total length of 1824 bp using GAP 4 of the Staden package (Version 1.6.0 for Windows). The open reading frames of the assembled sequences were aligned with sequences of other H genes collected from different parts of the world and available in GenBank using MAFFT (Katoh et al., 2002; 2005) . The nucleotide sequences were translated into amino acids using the tranalign programme in EMBOSS (Rice et al., 2000) .
A transversional model with a proportion of invariable sites and a gamma-shaped distribution of rates across sites (TVM+I+Γ) substitution model determined by Modeltest v3.7 (Posada and Crandall, 1998) , PAUP* v4b10 (Swofford, 2003) and MrBayes v3.1.1 (Ronquist and Huelsenbeck, 2003; Huelsenbeck and Ronquist, 2001 ) were used to explore distance (Neighbourjoining) and character (Bayesian, Maximum likelihood) based phylogenetic methods of the nucleotide sequences. The consensus trees were edited in MEGA v4 (Kumar et al., 1994; Tamura et al., 2007) . The phocine distemper virus (PDV) with GenBank accession number AF479277 was indicated as outgroup in all 3 of the analysis types.
Nucleotide Sequence Accession Numbers
The nucleotide sequence accession numbers in the GenBank database of H gene sequences of the isolates from dogs in South Africa and that of vaccine strains available in South Africa are listed in Table I . The nucleotide sequence accession numbers in the GenBank database of H gene sequences of the reference strains used in this study are: Onderstepoort (AF378705), Convac (Z35493), Snyder Hill (AF259552) and A75/17 (AF164967).
RESULTS
The cytopathic effects of giant multinucleated syncytium formation and detachment of cells was observed. The presence of CDV was confirmed with a direct fluorescent antibody test and electronmicroscopy as described earlier (Woma and van Vuuren, 2009 ). For the purpose of comparison, 5 CDV vaccines in use in South Africa were also obtained and the RNA extracted. The profiles of these field CDV strains and that of the vaccines in use in South Africa are summarized in table I. The RT-PCRs performed according to conditions described above resulted in amplicons of the expected size of 2100 bp (Figures 2 and 3) using published primer pairs (Table II) (Lan et al., 2006) with minor modifications.
The determined nucleotide sequences of the amplicons were deposited into GenBank under the ascension numbers shown in Table I (Woma et al., 2010) . The national center for biotechnology information basic alignment search tool (NCBI BLAST) was optimized for highly similar sequences (megablast) and the South African isolates showed 95% maximum identity to a Hungarian strain (GenBank accession no EF095750), an isolates from a Greenlandic dog (Z47760), isolate from a Chinese lesser panda (AF178039), a German dog isolate (X85000), the wild-type strain A75/17 (AF164967) and a United States ferret strain 5804 (AY386315). However, sequences from 4 of the commercial vaccines (A, B, C, and E) retailed in South Africa showed 98 -99% maximum identity to vaccine strain (AB212966), the Onderstepoort vaccine strain (AF378705), the Lederle vaccine strain (DQ903854) and the Convac vaccine strain (Z35493). Unexpectedly, one of the commercial vaccine (D) showed 99% maximum identity to the Hungarian strain (EF095750) and the Chinese lesser panda isolate (AF178039). The sequenced genome fragments from each of the field isolates were translated, resulting in 607 amino acid (aa) long polypeptides, representing the complete sequences of the H protein. However, only sequences of commercial vaccines D and C yielded 607 amino acids. Vaccines A, B and E had only 604 amino acids like the Onderstepoort and some other earlier vaccine strains available in GenBank. In the neighbour joining tree (Fig. 1) , the outgroup (PDV) splits first into the lineage America 1 (bootstrap value 100%), it then splits into the lineage Asia 2 (bootstrap value 100%) and a group consisting of the America 2 (bootstrap value 97%), Europe (bootstrap value 100%) and Asia 1 (95%). The tree then finally splits into the Arctic (99%) and the South African field isolates groups (100%).
We sequenced some of these commercial vaccines retailed in South Africa to see if there is any genetic variation as compared to current field isolates. Four (vaccine A, B, C, and E) out of the 5 vaccines sequenced showed 99% nucleotide identity to each other and to the Onderstepoort CDV and group together with the Onderstepoort strain in lineage America 1. The other one (vaccine D) showed 99% nucleotide identity to a Hungarian vaccine strain (EF095750) and to a Chinese CDV isolate from lesser panda (AF178039). Vaccine D grouped with other CDV strains in lineage America 2 which has many CDVs of non canine species. These vaccines retailed in South Africa are genetically distinct from the circulating wild-type strains as has been reported in other parts of the world (Calderon et al., 2007; Lan et al., 2006) . 
DISCUSSION
The five CDV positive dogs examined in this study had history of CDV vaccination. An unusual CDV lineage was detected in these dogs and phylogenetic analysis of the H protein sequence of the vaccines in use in South Africa showed that the field strains from this study are genetically distinct from vaccine viruses and other CDV lineages circulating in other parts of the world.
Outbreaks of canine distemper have been reported among vaccinated dogs (Harder et al., 1996; Harder and Osterhaus, 1997; Liermann et al., 1998; MombergJorgensen, 1951; Ott et al., 1957; SimonMartinez et al., 2007) . Morbillivirus vaccination failures have also been reported (Blixenkrone-Moller et al., 1993) . Clusters of clinical outbreaks have been recorded among human populations with documented measles vaccination coverage of more than 90% (Gustafson et al., 1987) . Assuming that quality, handling and administration of the vaccines were appropriate in the present cases of vaccination failure, an extraordinarily high infection pressure and immune dysfunctions of the individuals, which may be inherent or due to stress or interference with other current infections at the time of vaccination or at the time of natural exposure, could be important factors responsible for lack of protection against severe clinical disease. It is possible that part of the apparent immunization failures in properly vaccinated dogs may indicate changes in the biological properties of the current field viruses (Blixenkrone-Moller et al.,1993) .
Vaccination with modified live vaccine was performed in the cases obtained in this study. Importantly, the CDV strains detected in these clinical cases were genetically distinct from known vaccine strains, as has been demonstrated in previous studies of other CDV positive cases with history of CDV vaccination (Bolt et al., 1997; Calderon et al., 2007; Haas et al., 1999; Iwatsuki et al., 2000; Lednicky et al., 2004; Maes et al., 2003; Martella et al., 2006) . These observations suggest that a recent reversion of vaccine virus to virulence was not likely to be the cause of the clinical CDV disease seen in dogs for which vaccine had been recently used. The possibility was considered that vaccine failed to have the intended result due to either existing maternal immunity, vaccine failures or the emergence of new strains that are divergent enough to evade immune protection elicited by the vaccines used (Pardo et al., 2007) . Thus, renewed efforts may be required by vaccine manufacturers to ensure adequate protection following immunization of dogs against CDV. More studies on genetic characterization will be required to evaluate the efficacies of current CDV vaccines and develop new vaccines against emergence of novel CDV strains. A thorough characterization of the genetic diversity of CDVs can improve our understanding of its emergence, epidemiology, and aid development of new vaccines and diagnostic tests.
There are other distemper vaccines in the global market but the most frequently used products in South Africa are manufactured by Fort Dodge, Pfizer, Intervet, Merial and Virbac. However, it is hoped that the effectiveness of the currently employed vaccines is not partially compromised by the extent of genetic variation observed since CDV is a monotypic virus as defined by polyclonal antisera.
For the purpose of this phylogenetic analysis, we used the Onderstepoort strain (GenBank accession no AF378705), the Convac strain (Z35493), the Synder Hill strain (AF 259552) and the A75/17 strain (AF164967) as references. The Onderstepoort CDV was derived from the so called Green's distemperoid virus (Green & Carlson, 1945) which had been isolated from a natural distemper case and serially passaged in ferrets. The ferret-passaged virus was then adapted to chicken eggs and passaged in this system numerous times, after which it was called Onderstepoort-CDV (Haig, 1956) . Onderstepoort-CDV is considered to be completely apathogenic and is used in vaccines (Stettler et al., 1997) .
The Convac strain is also used as a vaccine strain but details on its origin is scanty. The Synder Hill strain is also used for vaccine production. Snyder Hill CDV was isolated from a natural case of distemper and has been serially passaged through direct intracerebral inoculation in dogs (Stettler et al., 1997) . Several features of experimental Synder Hill-CDV infection are similar to the wild type CDV infection (Stettler et al., 1997) . The A75/17 CDV is regarded as the virulent prototype of field CDV isolates. A75/17 is a virulent wild strain isolated from a dog with spontaneous distemper. Under experimental conditions, this virus causes a demyelinating disease and persistent infection of the CNS as seen in natural distemper (Appel, 1969) . Current South African field isolates examined in this study did not cluster with the Onderstepoort strain in lineage America 1 but however, showed about 95% nucleotide identity to the A75/17 strain on NCBI BLAST. Considering the more than 60-year interval between the isolation of the Onderstepoort strain and our present field isolates, such far genetic relationship is not unexpected.
In conclusion, the CDV positive dogs with a history of vaccination were infected with wild-type CDV having a genetic relationship far from the vaccine strain, and showed no evidence of reversion to virulence of vaccine virus.The more commonly reported mutations are in the genes coding for the hemaglutinin/attachment protein H, the fusion protein F and the nucleocapsid protein N (Mochizuki et al., 1999 
